Literature DB >> 23108024

Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma.

Qingyan Liu1, Itziar Salaverria, Stefania Pittaluga, Armin G Jegalian, Liqiang Xi, Reiner Siebert, Mark Raffeld, Stephen M Hewitt, Elaine S Jaffe.   

Abstract

Follicular lymphoma (FL), a common lymphoma in adults, occurs rarely in pediatric and young adult patients. Most pediatric cases have been described as grade 3, but the criteria to distinguish the pediatric variant of FL (PFL) from usual FL (UFL) seen in adults are not well defined. We undertook a study of FL in patients under the age of 30. We identified 63 cases, which were analyzed by morphology, immunohistochemistry, and polymerase chain reaction analysis of IGH@ and IGK@ clonality. These data were correlated with clinical findings including stage, treatment, and outcome. Among the 63 cases, 34 cases were classified as PFL: 22 presenting in lymph nodes, 8 in the Waldeyer ring, and 4 in the testis. Clonal immunoglobulin gene rearrangement was detected in 97% of PFL cases, but fluorescence in situ hybridization analysis showed an absence of the BCL2/IGH@ translocation in all cases tested. Twenty-nine cases were classified as UFL, 28 of which presented in lymph nodes. The nodal PFLs were observed exclusively in male patients in both children and young adults with a median age of 15 years. They showed marked head/neck predilection, blastoid cytologic features with a high proliferation rate, lack of BCL2 protein and t(14;18), low clinical stage at presentation, and good prognosis. PFLs involving the Waldeyer ring were distinguished by MUM1 expression, 50% (3/6) of which carried IRF4 breaks. BCL2 expression was common (63%) in the absence of BCL2/IGH@ translocation. UFLs were more common in female patients, exclusively in young adults (median age, 24 y), with no cases reported in patients under the age of 18. Twenty-five of 29 cases were of grade 1-2, and 4 cases were classified as grade 3A. They exhibited a higher clinical stage at presentation. Eighty-three percent expressed BCL2. Our results indicate that histologic and immunophenotypic criteria can reliably separate PFL and UFL and that UFL is exceptionally rare in the pediatric age group. PFL associated with particular anatomic sites have distinctive features and should be evaluated separately in future clinical and biological studies.

Entities:  

Mesh:

Year:  2013        PMID: 23108024      PMCID: PMC3566339          DOI: 10.1097/PAS.0b013e31826b9b57

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  26 in total

1.  The CBFA2T3/ACSF3 locus is recurrently involved in IGH chromosomal translocation t(14;16)(q32;q24) in pediatric B-cell lymphoma with germinal center phenotype.

Authors:  Itziar Salaverria; Takashi Akasaka; Stefan Gesk; Monika Szczepanowski; Birgit Burkhardt; Lana Harder; Christine Damm-Welk; Ilske Oschlies; Wolfram Klapper; Martin J S Dyer; Reiner Siebert
Journal:  Genes Chromosomes Cancer       Date:  2012-04       Impact factor: 5.006

2.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

3.  Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.

Authors:  Noraidah Masir; Lisa J Campbell; Margaret Jones; David Y Mason
Journal:  Pathology       Date:  2010-04       Impact factor: 5.306

4.  Follicular lymphomas in pediatric patients.

Authors:  A Pinto; R E Hutchison; L H Grant; C L Trevenen; C W Berard
Journal:  Mod Pathol       Date:  1990-05       Impact factor: 7.842

5.  Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.

Authors:  Itziar Salaverria; Claudia Philipp; Ilske Oschlies; Christian W Kohler; Markus Kreuz; Monika Szczepanowski; Birgit Burkhardt; Heiko Trautmann; Stefan Gesk; Miroslaw Andrusiewicz; Hilmar Berger; Miriam Fey; Lana Harder; Dirk Hasenclever; Michael Hummel; Markus Loeffler; Friederike Mahn; Idoia Martin-Guerrero; Shoji Pellissery; Christiane Pott; Michael Pfreundschuh; Alfred Reiter; Julia Richter; Maciej Rosolowski; Carsten Schwaenen; Harald Stein; Lorenz Trümper; Swen Wessendorf; Rainer Spang; Ralf Küppers; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2011-04-12       Impact factor: 22.113

6.  Distribution of PD-1+ lymphocytes in reactive lymphadenopathies.

Authors:  Simone Muenst; Stephan Dirnhofer; Alexandar Tzankov
Journal:  Pathobiology       Date:  2010-02-25       Impact factor: 4.342

7.  Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms.

Authors:  I Ramasamy; M Brisco; A Morley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

8.  Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials.

Authors:  Ilske Oschlies; Itziar Salaverria; Friederike Mahn; Andrea Meinhardt; Martin Zimmermann; Wilhelm Woessmann; Birgit Burkhardt; Stefan Gesk; Matthias Krams; Alfred Reiter; Reiner Siebert; Wolfram Klapper
Journal:  Haematologica       Date:  2009-08-13       Impact factor: 9.941

9.  Marginal zone B-cell lymphoma in children and young adults.

Authors:  Lekidelu Taddesse-Heath; Stefania Pittaluga; Lynn Sorbara; Mary Bussey; Mark Raffeld; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2003-04       Impact factor: 6.394

10.  Diagnostic and prognostic utility of PD-1 in B cell lymphomas.

Authors:  S Muenst; S Hoeller; N Willi; S Dirnhofera; A Tzankov
Journal:  Dis Markers       Date:  2010       Impact factor: 3.434

View more
  20 in total

1.  Follicular lymphomas: a tapestry of common and contrasting threads.

Authors:  Elaine S Jaffe
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

Review 2.  Diagnosis and classification of lymphoma: Impact of technical advances.

Authors:  Elaine S Jaffe
Journal:  Semin Hematol       Date:  2018-05-29       Impact factor: 3.851

Review 3.  Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice.

Authors:  Elaine S Jaffe; Paul M Barr; Sonali M Smith
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

Review 4.  Early lymphoid lesions: conceptual, diagnostic and clinical challenges.

Authors:  Karthik A Ganapathi; Stefania Pittaluga; Oreofe O Odejide; Arnold S Freedman; Elaine S Jaffe
Journal:  Haematologica       Date:  2014-09       Impact factor: 9.941

5.  Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.

Authors:  Abner Louissaint; Kristian T Schafernak; Julia T Geyer; Alexandra E Kovach; Mahmoud Ghandi; Dita Gratzinger; Christine G Roth; Christian N Paxton; Sunhee Kim; Chungdak Namgyal; Ryan Morin; Elizabeth A Morgan; Donna S Neuberg; Sarah T South; Marian H Harris; Robert P Hasserjian; Ephraim P Hochberg; Levi A Garraway; Nancy Lee Harris; David M Weinstock
Journal:  Blood       Date:  2016-06-20       Impact factor: 22.113

Review 6.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

7.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.

Authors:  Noah A Brown; Kojo S J Elenitoba-Johnson
Journal:  Head Neck Pathol       Date:  2017-02-28

8.  Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.

Authors:  Joan Enric Ramis-Zaldivar; Blanca Gonzalez-Farré; Olga Balagué; Verónica Celis; Ferran Nadeu; Julia Salmerón-Villalobos; Mara Andrés; Idoia Martin-Guerrero; Marta Garrido-Pontnou; Ayman Gaafar; Mariona Suñol; Carmen Bárcena; Federico Garcia-Bragado; Maitane Andión; Daniel Azorín; Itziar Astigarraga; Maria Sagaseta de Ilurdoz; Constantino Sábado; Soledad Gallego; Jaime Verdú-Amorós; Rafael Fernandez-Delgado; Vanesa Perez; Gustavo Tapia; Anna Mozos; Montserrat Torrent; Palma Solano-Páez; Alfredo Rivas-Delgado; Ivan Dlouhy; Guillem Clot; Anna Enjuanes; Armando López-Guillermo; Pallavi Galera; Matthew J Oberley; Alanna Maguire; Colleen Ramsower; Lisa M Rimsza; Leticia Quintanilla-Martinez; Elaine S Jaffe; Elías Campo; Itziar Salaverria
Journal:  Blood       Date:  2020-01-23       Impact factor: 22.113

9.  Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.

Authors:  Idoia Martin-Guerrero; Itziar Salaverria; Birgit Burkhardt; Monika Szczepanowski; Michael Baudis; Susanne Bens; Laurence de Leval; Africa Garcia-Orad; Heike Horn; Jasmin Lisfeld; Shoji Pellissery; Wolfram Klapper; Ilske Oschlies; Reiner Siebert
Journal:  Haematologica       Date:  2013-02-26       Impact factor: 9.941

10.  Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

Authors:  C Casulo; B Day; K L Dawson; X Zhou; C R Flowers; C M Farber; J D Hainsworth; J R Cerhan; B K Link; A D Zelenetz; J W Friedberg
Journal:  Ann Oncol       Date:  2015-09-11       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.